Arnhold LLC Bristol Myers Squibb CO Transaction History

Arnhold LLC

$961 Million
Q3 2024

A detailed history of Arnhold LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arnhold LLC holds 471,940 shares of BMY stock, worth $27.3 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares

471,940

Previous 502,763 6.13%

Holding current value

$27.3 Million

Previous $20.9 Million 16.97%

% of portfolio

2.54%

Previous 2.3%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $1.22 Million - $1.6 Million	-30,823 Reduced 6.13%	471,940 $24.4 Million
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $5.88 Million - $7.74 Million	146,070 Added 40.95%	502,763 $20.9 Million
Q1 2024 May 07, 2024	BUY	$47.98 - $54.4 $1.77 Million - $2.01 Million	36,890 Added 11.54%	356,693 $19.3 Million
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $3.13 Million - $3.73 Million	64,533 Added 25.28%	319,803 $16.4 Million
Q3 2023 Oct 24, 2023	BUY	$57.89 - $64.73 $1.36 Million - $1.52 Million	23,535 Added 10.16%	255,270 $14.8 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $122,705 - $136,245	-1,926 Reduced 0.82%	231,735 $14.8 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $302,923 - $343,583	4,610 Added 2.01%	233,661 $16.2 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $677,883 - $802,709	-9,899 Reduced 4.14%	229,051 $16.5 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $5.09 Million - $5.61 Million	-70,157 Reduced 22.7%	238,950 $18.4 Million
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $7.91 Million - $9.48 Million	-128,610 Reduced 29.38%	309,107 $22.6 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $6.84 Million - $7.97 Million	127,492 Added 41.1%	437,717 $27.3 Million
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $274,134 - $321,113	4,633 Added 1.52%	310,225 $18.4 Million
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $30,955 - $33,710	-500 Reduced 0.16%	305,592 $20.4 Million
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $5,934 - $6,673	100 Added 0.03%	306,092 $19.3 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $8,776 - $9,945	-152 Reduced 0.05%	305,992 $19 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $2.39 Million - $2.79 Million	43,558 Added 16.59%	306,144 $18 Million
Q1 2020 Apr 17, 2020	BUY	$46.4 - $67.43 $1.09 Million - $1.58 Million	23,453 Added 9.81%	262,586 $14.6 Million
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $5.27 Million - $6.88 Million	-107,174 Reduced 30.95%	239,133 $15.4 Million
Q3 2019 Oct 29, 2019	BUY	$42.77 - $50.71 $753,308 - $893,155	17,613 Added 5.36%	346,307 $17.6 Million
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $2.42 Million - $2.68 Million	54,335 Added 19.8%	328,694 $14.9 Million
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $2.85 Million - $3.4 Million	63,231 Added 29.95%	274,359 $13.1 Million
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $2.13 Million - $2.76 Million	43,694 Added 26.1%	211,128 $11 Million
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $639,928 - $721,788	-11,595 Reduced 6.48%	167,434 $10.4 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $3.41 Million - $4.25 Million	67,500 Added 60.52%	179,029 $9.91 Million
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $6.68 Million - $7.69 Million	111,529 New	111,529 $7.05 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arnhold LLC with notifications on news.

Account